Annual Drug Patent Expirations for GALAFOLD
Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are forty-one patents protecting this drug.
This drug has one hundred and twenty-eight patent family members in twenty-seven countries.
The generic ingredient in GALAFOLD is migalastat hydrochloride. Additional details are available on the migalastat hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for Amicus Therap drug GALAFOLD